Wednesday 22nd May 2013 |
Text too small? |
New Zealand Post, the state-owned postal service, says Standard & Poor's move to lower the outlook on its A+ credit rating won't affect debt on issue or create any problems for its financing activities.
S&P yesterday affirmed the ratings of NZ Post and its KiwiBank subsidiary while lowering the long-term outlook to negative from stable, saying increasing economic risks in New Zealand could undermine the credit-standing of KiwiBank, which makes up 70 percent of the group's earnings.
NZ Post chief financial officer Mark Yeoman said the outlook change is unlikely to affect its short-term commercial paper programme, which currently stands at about $30 million, and the next major credit event for the company is November 2014 call date for its $200 million of 2039 bonds
"This is not going to impact debt on issue," Yeoman said. "It's not a downgrade."
The negative outlook means there's a one-in-three chance of a cut in the next two years. S&P said while it deconsolidates KiwiBank in its credit metrics for NZ Post, it does take into account the contingent liability of NZ Post's guarantee of KiwiBank's $12.3 billion of deposits and $1.5 billion of borrowings.
As at Dec. 31, KiwiBank had some $1.69 billion outstanding under its debt funding programme, with the bulk comprising $601 million in its short-term euro commercial paper and $469 million in its Australian medium term note programme. A bank spokesman said the S&P move may have a small impact of wholesale trading but nothing of significance.
NZ Post has access to an uncalled $300 million capital facility from the government and its credit rating is supported by the "very high" likelihood of government support in the event of financial distress.
BusinessDesk.co.nz
No comments yet
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report